Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
ASAHI Surgical Robotics has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 MedTech Startups in APAC 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Takehiro Ando, CEO.
Company
ASAHI Surgical Robotics
Management
Takehiro Ando, CEO
Description
ASAHI Surgical Robotics, a startup company dedicated in developing novel and high-quality surgical robots for laparoscopic surgery The company vision is to accelerate the innovation to lead the building of ‘Startup Ecosystem’ in Japan. The company believes that robotic cooperated surgery system requires the sophisticated operation interface. For this, the company work on the implementation of the controlling system to develop “Another Surgeon” usually called ‘ANSUR.’ The concept of ANSUR, enables surgeon pursuing high usability of robot to provide optimized care to more patients all over the world. The novel control device was fabricated to reduce the load of surgeons which results in endoscopic surgery in preferable circumstance.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
